Walgreens Boots Alliance, Inc. (NASDAQ:W(BA)) has been assigned an average recommendation of “Hold” from the twenty-one brokerages that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $44.22.
A number of research analysts recently commented on the stock. Mizuho upped their price target on shares of Walgreens Boots Alliance from $37.00 to $47.00 and gave the company a “neutral” rating in a research note on Monday, January 11th. Robert W. Baird raised Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and upped their target price for the company from $41.00 to $55.00 in a research report on Monday, January 11th. Truist Financial lifted their price target on Walgreens Boots Alliance from $40.00 to $44.00 in a report on Tuesday, January 5th. Credit Suisse Group started coverage on Walgreens Boots Alliance in a research note on Thursday, January 7th. They issued a “neutral” rating and a $42.00 price target for the company. Finally, Barclays raised their price target on shares of Walgreens Boots Alliance from $40.00 to $47.00 and gave the stock an “equal weight” rating in a research report on Friday, January 8th.
NASDAQ:W(BA) traded down $0.18 on Monday, hitting $47.27. The company’s stock had a trading volume of 36,264 shares, compared to its average volume of 7,960,427. Walgreens Boots Alliance has a one year low of $33.36 and a one year high of $54.53. The firm has a market capitalization of $40.84 billion, a P/E ratio of 93.66, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. The stock has a fifty day moving average of $43.08 and a two-hundred day moving average of $39.65. The company has a current ratio of 0.67, a quick ratio of 0.32 and a debt-to-equity ratio of 0.58.
Walgreens Boots Alliance (NASDAQ:W(BA)) last posted its quarterly earnings results on Wednesday, January 6th. The pharmacy operator reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.19. Walgreens Boots Alliance had a return on equity of 18.33% and a net margin of 0.33%. The business had revenue of $36.31 billion for the quarter, compared to analysts’ expectations of $35.01 billion. During the same quarter in the prior year, the business earned $1.37 EPS. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. As a group, sell-side analysts anticipate that Walgreens Boots Alliance will post 4.84 EPS for the current year.
In related news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the firm’s stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $41.55, for a total transaction of $207,750.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 16.91% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Prudential PLC acquired a new stake in Walgreens Boots Alliance in the third quarter valued at $72,774,000. Equity Investment Corp acquired a new position in Walgreens Boots Alliance during the 3rd quarter worth about $42,556,000. State Street Corp grew its position in shares of Walgreens Boots Alliance by 2.5% in the 3rd quarter. State Street Corp now owns 46,444,706 shares of the pharmacy operator’s stock valued at $1,668,294,000 after buying an additional 1,115,564 shares during the last quarter. Morgan Stanley increased its stake in shares of Walgreens Boots Alliance by 10.2% in the third quarter. Morgan Stanley now owns 7,460,256 shares of the pharmacy operator’s stock valued at $267,973,000 after buying an additional 691,989 shares during the period. Finally, ProShare Advisors LLC raised its position in shares of Walgreens Boots Alliance by 20.0% during the third quarter. ProShare Advisors LLC now owns 3,193,690 shares of the pharmacy operator’s stock worth $114,717,000 after acquiring an additional 531,981 shares during the last quarter. Institutional investors and hedge funds own 55.96% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Featured Article: Blue-Chip Stocks
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]rketbeat.com.